WARREN, N.J., March 10, 2017 /PRNewswire/ -- Roka
Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company
focused on providing advanced testing solutions for the detection
of foodborne pathogens, today announced that Mary Duseau, CEO will present at the
29th Annual Roth Conference on March 14 at 8:00am
PT. The conference will be held at The Ritz –Carlton,
Dana Point CA.
About Roka Bioscience
Roka Bioscience is a molecular diagnostics company focused on
developing and commercializing advanced testing solutions for the
food safety testing market. Our Atlas Detection Assays incorporate
our advanced molecular technologies and are performed on our
"sample-in, result-out" Atlas System that automates all aspects of
molecular diagnostic testing on a single, integrated platform. The
Atlas System and Detection Assays are designed to provide our
customers with accurate and rapid test results with reduced labor
costs and improved laboratory efficiencies. For more
information, visit http://rokabio.com.
Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-29th-annual-roth-conference-300421537.html
SOURCE Roka Bioscience, Inc.